Clinical And Laboratory Predictors Of Mortality In Patients Hospitalized For Liver Cirrhosis In Cameroon - Chi Fru Mcwright

Conference on Liver Disease in Africa (COLDA) 2020

Devenir Au Long Cours Des Patients Traités Par Analogues Nucléot(S)Idiques Pour Cirrhose Virale B À L’Hôpital Principal De Dakar - I. Diallo

Conference on Liver Disease in Africa (COLDA) 2020

Impact Of Treating Hyperuricemic Nafld Patients With Allopurinol On Cytokeratin 18: A Pilot Study - M. Mokhles

Conference on Liver Disease in Africa (COLDA) 2020

Les Hépatites Auto-Immunes À L’Hôpital Principal De Dakar : Étude Rétrospective À Propos De 19 Cas - Abdoul Sow

Conference on Liver Disease in Africa (COLDA) 2020

Hepatitis C Elimination In Rwanda: The Case-Finding Journey - Sabine Umuraza

Conference on Liver Disease in Africa (COLDA) 2020

Rwanda’S Journey To Achieve Low Prices For Hepatitis C Treatment Drugs - N. Hitimana

Conference on Liver Disease in Africa (COLDA) 2020

Prevalence Of Hepatitis Among Select Key Populations In Botswana – Results Of The 2Nd Biological And Behavioral Surveillance Survey - K. Kusi

Conference on Liver Disease in Africa (COLDA) 2020

Risk Of Residual Transmission Of Hepatitis B Virus (Hbv), Hepatitis C Virus (Hcv) And Human Immunodeficiency Virus (Hiv) Through Blood Transfusion In Burkina Faso: Preliminary Results - A. M. Sanou

Conference on Liver Disease in Africa (COLDA) 2020

Safety And Efficacy Of Different Direct-Acting Antiviral Treatment Regimens In Hepatitis C Infected Patients With Renal Impairment: A Single Center Experience - T. George Michael

Conference on Liver Disease in Africa (COLDA) 2020

Assessment Of Protective Serum Anti-Hbsab Levels Among Previously Hbv Vaccinated Medical Residents And Its Relation To Duration And Doses Of Vaccine – Single Center Study - Mahmoud Essam

Conference on Liver Disease in Africa (COLDA) 2020

Infection Chronique Au Virus De L’Hépatite B (Vhb) À Antigène Hbe Négatif Au Sénégal : Devenir Des Patients Suivis À L’Hôpital Principal De Dakar - I. Diallo

Conference on Liver Disease in Africa (COLDA) 2020

Genotype Distribution Of Hepatitis C Virus: Experience In Maputo, Mozambique - A. Loarec

Conference on Liver Disease in Africa (COLDA) 2020

L’Hépatite Virale B Chronique Chez Les Patients Porteurs De L’Antigène Hbe : Aspects Diagnostiques, Thérapeutiques Et Évolutifs - N. A. Guingane

Conference on Liver Disease in Africa (COLDA) 2020

Evaluation Of The Efficacy Of The Egyptian Program For Hepatitis B Virus Vaccination: A Cross Sectional National Survey - M. Mokhles

Conference on Liver Disease in Africa (COLDA) 2020

Identifying Gaps Across The Cascade Of Care For The Prevention Of Hbv Mother-To-Child Transmission In Burkina Faso: Findings From The Real World - Nanelin Alice Guingane

Conference on Liver Disease in Africa (COLDA) 2020

Highlights of the Symposium on Managing Today’s Complex HIV Patient

Clinical Update: Highly Treatment- Experienced Patients - Michael Kozal, MD

Global HIV Clinical Forum 2020

Clinical Case: Potential Challenges of Drug Interactions of Long-Acting Agents - Catia Marzolini, PharmD, PhD

Global HIV Clinical Forum 2020

HIV Prevention: The Second Wave of Choices - Richard Elion, MD

Global HIV Clinical Forum 2020

HIV Vaccines - Where Are We? - Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

Global HIV Clinical Forum 2020

Therapeutic approaches for a sustainable remission and cure - Steven Deeks, MD

Global HIV Clinical Forum 2020

Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCP

Global HIV Clinical Forum 2020

Introducing New Therapies in Middle-Income Countries - Pedro Cahn, MD, PhD

Global HIV Clinical Forum 2020

Strategies for Management of Drug-Drug Interactions With Long-Acting Therapies - David Back, PhD

Global HIV Clinical Forum 2020